Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Cell Death
100%
Fingolimod
100%
CD74
100%
Milatuzumab
100%
Mantle Cell Lymphoma Cell
100%
Lymphoma Cell
50%
Mantle Cell Lymphoma Cell Line
25%
Cytosol
12%
Immunosuppressive Drug
12%
Tumor Cell
12%
Cyclin D1
12%
B Cell
12%
Autophagy
12%
Treatment of Multiple Sclerosis
12%
Keyphrases
Cell Death
100%
FTY720
100%
Lymphoma Cells
100%
Mantle Cell Lymphoma
100%
Combination Therapy
11%
Induced Cell Death
11%
Median Survival
11%
Combined Modality Therapy
11%
Therapeutic Action
11%
Combination Treatment
11%
Clinical Evaluation
11%
Cyclin D1 (CCND1)
11%
Blastic
11%
Multiple Sclerosis Treatment
11%
Phospho-Akt
11%
Immunosuppressive Drugs
11%
LC3-II
11%
Putative Drug Targets
11%
Downmodulation
11%
B-cell Malignancies
11%
Lysosomal Acid Lipase
11%
Lysosomal Compartment
11%
Autophagosome
11%
Cellcycle
11%
Lysosomal Membrane Permeabilization
11%
Primary Tumor Cells
11%
Medicine and Dentistry
Cell Death
100%
Fingolimod
100%
Milatuzumab
100%
Mantle Cell Lymphoma Cell
100%
Mantle Cell Lymphoma
50%
Mantle Cell Lymphoma Cell Line
25%
Clinical Trial
12%
Combination Therapy
12%
Protein Kinase B
12%
Tumor Cell
12%
Cancer
12%
Hydrolase
12%
Cyclin D1
12%
Immunosuppressive Drug
12%
B Cell
12%
Primary Tumor
12%
Autophagy
12%
Cytosol
12%
Treatment of Multiple Sclerosis
12%
Pharmacology, Toxicology and Pharmaceutical Science
Fingolimod
100%
Mantle Cell Lymphoma
100%
Milatuzumab
100%
Clinical Trial
11%
Protein Kinase B
11%
Hydrolase
11%
Cyclin D1
11%
Immunosuppressive Agent
11%
Combination Therapy
11%
Primary Tumor
11%
Multiple Sclerosis
11%